A Lyme vaccine is in late-stage trials. Could an anti-tick vaccine be next?

As a vaccine against Lyme disease enters late-stage clinical trials, scientists around the globe are already looking beyond Lyme and exploring the possibility of an anti-tick vaccine that could effectively protect against all kinds of tick-borne diseases.

The research centers around a weird — and some would say wonderful — phenomenon called acquired tick resistance (ATR).

Continue reading at Northeastern Global News.